Development of Papulopustular Rosacea during Nivolumab Therapy for Metastatic Cancer

Acta Derm Venereol. 2017 Apr 6;97(4):539-540. doi: 10.2340/00015555-2566.
No abstract available

MeSH terms

  • Administration, Cutaneous
  • Anti-Infective Agents / administration & dosage
  • Antibodies, Monoclonal / adverse effects*
  • Antineoplastic Agents / adverse effects*
  • Biopsy
  • Drug Eruptions / drug therapy
  • Drug Eruptions / etiology*
  • Drug Eruptions / pathology
  • Facial Dermatoses / chemically induced*
  • Facial Dermatoses / drug therapy
  • Facial Dermatoses / pathology
  • Female
  • Humans
  • Male
  • Neoplasm Metastasis
  • Neoplasms / drug therapy*
  • Neoplasms / pathology
  • Nivolumab
  • Rosacea / chemically induced*
  • Rosacea / drug therapy
  • Rosacea / pathology
  • Skin / drug effects*
  • Skin / pathology
  • Treatment Outcome

Substances

  • Anti-Infective Agents
  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Nivolumab